Submitted by Anonymous (not verified) on 23 September 2025 - 12:25
Human medicines European public assessment report (EPAR): Cegfila (previously Pegfilgrastim Mundipharma), pegfilgrastim, Date of authorisation: 19/12/2019, Revision: 9, Status: Authorised
Source: